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osting by EAbstract Gymnema sylvestre R. Br. (G. sylvestre) belonging to the family Asclepiadaceae, has been
used as a traditional medicine plant in Africa, Australia and Asia especially in India.
Aim of the study: The present study aimed to clarify the effect of G. sylvestre leaves extract on
several physiological parameters of diabetic rats.
Materials and methods: G. sylvestre leaves extract (18 mg/kg body weight) was orally adminis-
tered for 30 days to normal and streptozotocin (STZ) diabetic rats.
Results: STZ-diabetic rats exhibited a signiﬁcant increase in plasma glucose, liver function
enzymes [alanine aminotransaminase (ALT) and aspartate aminotransaminase (AST)], triglycer-
ides, total cholesterol, LDL-cholesterol malondialdehyde, catalase, reduced glutathione and a sig-
niﬁcant decrease in insulin, HDL-cholesterol and erythrocyte superoxide dismutase levels.
Treatment diabetic rats with G. sylvestre leaves extract signiﬁcantly decreased plasma glucose,
ALT, AST, triglycerides, total cholesterol, LDL-cholesterol, malondialdehyde and signiﬁcantly
increased insulin, HDL-cholesterol and erythrocyte superoxide dismutase levels compared to
untreated diabetic rats.
Conclusion: It could be concluded that G. sylvestre leaves extract treated diabetic rats’ complica-
tions including hyperglycemia, hypoinsulinemia, hyperlipidemia and oxidative stress.
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lsevier1. Introduction
Diabetes mellitus (DM) is a metabolic disorder characterized
by hyperglycemia resulting from defective insulin secretion,
resistance to insulin action or both (Jarald et al., 2008; Vasi
and Austin, 2009; Khan et al., 2012). DM is a widespread
disease, associates with chronic micro- and macro-vascular
complications (Goycheva et al., 2006; Ahmed et al., 2011;
Aralelimath and Bhise, 2012). Total recovery from diabetes
has not been reported up to now and this explains the intensive
studies done on it.
136Untreated diabetes leads to serious complications or even
premature death. The treatment of diabetes mellitus is based
on insulin and/or oral hypoglycemic drugs (Daisy et al.,
2009). These drugs act by various mechanisms to control the
blood glucose level, but many side-effects have been reported
(Patel et al., 2012). Therefore, there is considerable interest
in the ﬁeld of medicinal plants due to their natural origin
and less side effects (Jarald et al., 2008). One of these medicinal
plants is Gymnema sylvestre (Gurmar), which means sugar kill-
er (Najaﬁ and Deokule, 2011). It is a wild plant that grows in
the open forest in India, China, Indonesia, Japan, Malaysia,
Sri Lanka, Vietnam, and South Africa (Gurav et al., 2007;
Spasov et al., 2008). The leaves of the plant in particular are
used as antiviral, diuretic, antiallergic, hypoglycemic, hypolip-
idemic, antibiotic, in stomach pains and in rheumatism (Saneja
et al., 2010).
Most studies on G. sylvestre leaves extract focused on its
role as hypoglycemic medicinal plant, but the present study
demonstrates the effect of G. sylvestre leaves extract (18 mg/
kg body weight) on several etiological factors of STZ-diabetic
rats including hyperglycemia, hypoinsulinemia, hyperlipidemia
and oxidative stress at the same time.
2. Materials and methods
2.1. Experimental animals
White male albino rats (Rattus norvegicus) weighing
200 ± 10 g were purchased from the Center of Laboratory
animals, venoms & crude antisera production, Helwan, Cairo,
Egypt. Animals were maintained under laboratory conditions
[temperature (20 ± 2 C) and photoperiod (12 h light and
12 h dark cycle)]. Animals were allowed ad libitum to food
and tap water. Rats were allowed to acclimatize for one week
before the onset of the experiment.
2.2. Diabetogenic agent and Gymnema sylvestre leaves extract
 Streptozotocin (STZ) was purchased from Sigma Company
(U.S.A) and given as a single intraperitoneal dose (45 mg/
kg body weight) dissolved in citrate buffer (pH 4.5) accord-
ing to El-Seiﬁ et al. (1993).
 Gymnema sylvestre (G. sylvestre) leaves extract is used as
drug called (Diaglu), that is produced by Arab Company
for Pharmaceuticals and Medicinal Plants (MEPACO)
Enshas El Raml, Sharkeiya, Egypt. Diaglu contains G. syl-
vestre leaves extract only. G. sylvestre leaves extract was
given in a dose of (18 mg/kg body weight) dissolved in
1 ml distilled water according to Paget and Barnes (1964).
Kirtikar and Basu (1998) classiﬁed G. sylvestre as the
following:Kingdom Plantae
Subkingdom Tracheobionta
Super division Spermatophyta
Division Magnoliophyta
Class Magnoliopsida
Subclass Asteridae
Order Gentianales
Family Asclepiadaceae
Genus Gymnema
Species sylvestre R. Br. Common name: Gurmar, Gymnema, Gurmari, Gurmarbo-
oti, periploca of the woods, and meshasring.
 Physicochemical properties: G. sylvestre leaves extract is
soluble in water and other polar solvents as it contains
monosaccharides. G. sylvestre leaves extract has an acidic
nature due to the presence of carboxylic groups. G. sylvestre
contains more than 20 triterpene saponins that form molec-
ular complexes with proteins, lipids, sterols and tannins
(Spasov et al., 2008).
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Diabetes mellitus was experimentally induced in rats previously
fasted for 12 h by a single intraperitoneal dose (45 mg/kg body
weight) of streptozotocin dissolved in citrate buffer (pH 4.5). In
order to overcome the hypoglycemic coma that occurs within
the ﬁrst 24 h following STZ injection, animals were given 5%glu-
cose solution instead of drinking water for 2 days until sustained
hyperglycemia was established (Abdel-Moneim et al., 2002).
Three days after streptozotocin injection, rats were screened for
blood glucose levels. Blood samples werewithdrawn from the lat-
eral tail vein and glucose concentration was measured from over-
night fasted animals (10–12 h). Rats having glucose ranging from
180 to 200 mg/dl were considered asmild diabetic and included in
the experiment according to (Abdel-Moneim et al., 2002).2.4. Experiment design
Rats under study were classiﬁed into ﬁve groups (6 rats each):
 Group I: normal rat group.
Rats of this group were given intragastrically 1 ml distilled
water once a day for 30 days.
 Group II: rat group injected with citrate buffer.
Rats of this group were injected with a single intraperito-
neal dose of 1 ml citrate buffer (pH 4.5).
 Group III: rat group supplemented with G. sylvestre leaves
extract.
Rats of this group were supplemented with G. sylvestre
leaves extract (18 mg/kg b.w.) dissolved in 1 ml distilled water
once a day for 30 days.
 Group IV: STZ-diabetic rat group.
Rats of this group were injected intraperitoneally with a single
dose (45 mg/kg b.w.) of STZ dissolved in citrate buffer (pH 4.5).
The diabetic rats were housed at the experimental condition
for 30 days.
 Group V: rat group treated with G. sylvestre leaves extract
post STZ-diabetic induction.
Rats of this group were treated intragastrically with G.
sylvestre leaves extract (18 mg/kg b.w.) dissolved in 1 ml dis-
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induction.
2.5. Blood sampling
At the end of the experimental period, animals of each group
were fasted about 12 h and then anesthetized by diethyl ether
inhalation (Sinet et al., 1984). Blood samples were collected
from post caval vein and directly transported to tubes contain-
ing ethylenediamine tetra-acetic acid (EDTA) (El-Gomhorya
Co. Egypt). All the tubes were centrifuged at 3000 rpm. for
15 min by Hittech centrifuge and plasma free of hemolysis
was separated and frozen at 20 C for the determination of
physiological parameters. Packed erythrocytes were washed
four times with isotonic solution (0.9% NaCl) and centrifuged
for 10 min at 3000 rpm. after each wash to remove the leftover
leukocytes. After the last wash erythrocytes were frozen at
20 C for the determination of superoxide dismutase level.
2.6. Determination of biochemical parameters
All parameters except insulin level were determined by Hitachi
(902) Automatic Analyzer.
 Plasma glucose level was determined according to the
method of Burtis and Ashwood (2006) using reagent kits
purchased from Roche Diagnostics (USA).
 Plasma insulin level was measured on a Thermo Scientiﬁc
Multiskan FC ELISA Reader by rat/mouse insulin ELISA
kits purchased from Millipore (USA).
 Plasma ALT and AST levels were determined according to
the method of Glick et al. (1986) using kits purchased from
Roche Diagnostics (USA).
 Plasma triglycerides, cholesterol, LDL-cholesterol and
HDL-cholesterol levels were determined according to the
methods of Shephard and Whiting (1990), Trinder (1969),
Wieland andSeidel (1983) andHatch andLees (1968), respec-
tively using kits purchased from Roche Diagnostics (USA).
 Plasma malondialdehyde, catalase, reduced glutathione and
erythrocyte superoxide dismutase levels were determined
according to the methods of Satoh (1978), Aebi (1984),
Beutler et al. (1963) and Nishikimi et al. (1972), respectively
using reagent kits purchased from Bio–diagnostic (Egypt).
2.7. Statistical analysis
Statistical analysis was performed using Statistical Package for
Social Science (SPSS) computer program, Version 15.00. The
values were analyzed by one-way analysis of variance (ANO-
VA) followed by Duncan’s multiple range test (Duncan,
1957). Data were expressed as mean ± SD. Values were con-
sidered signiﬁcant at p< 0.05.
3. Results
 Effect of G. sylvestre leaves extract on plasma glucose and
insulin levels.
Plasma glucose level was signiﬁcantly low (p< 0.05) in the
rat group supplemented with G. sylvestre leaves extract (groupIII) compared to those of control rat groups (groups I and II,
respectively). On the other hand, plasma glucose levels were
signiﬁcantly high in the diabetic rat group (group IV) and
the rat group treated with G. sylvestre leaves extract post dia-
betic induction (group V) in relation to those of control rat
groups. Plasma glucose level decreased signiﬁcantly in group
V compared to that of group IV (Table 1).
Plasma insulin level was signiﬁcantly high (p< 0.05) in
group III compared to those of groups I and II. On the other
hand, plasma insulin levels were signiﬁcantly low in groups IV
and V compared to those of groups I and II. Plasma insulin
level increased signiﬁcantly in group V compared to that of
group IV (Table 1).
 Effect of G. sylvestre leaves extract on plasma liver function
enzymes level.
Both plasma alanine aminotransaminase (ALT) and aspar-
tate aminotransaminase (AST) levels in group III showed a
non signiﬁcant difference (p< 0.05) in relation to those of
groups I and II. Plasma ALT and AST levels were signiﬁcantly
high in groups IV and V compared to those of groups I and II.
Plasma ALT and AST levels were signiﬁcantly low in group V
compared to those of group IV (Table 2).
 Effect of G. sylvestre leaves extract on plasma lipid proﬁle.
Plasma triglycerides, cholesterol and LDL-cholesterol levels
decreased signiﬁcantly (p< 0.05) in group III compared to
those of groups I and II. Plasma triglycerides, cholesterol
and LDL-cholesterol levels in groups IV and V were signiﬁ-
cantly high compared to those of groups I and group II. Plas-
ma triglycerides, cholesterol and LDL-cholesterol levels
decreased signiﬁcantly in group V compared to those of group
IV (Table 3).
Plasma HDL-cholesterol levels increased signiﬁcantly
(p< 0.05) in group III compared to those of groups I and
II. On the other hand, plasma HDL-cholesterol levels were sig-
niﬁcantly low compared to those of groups I and II. Plasma
HDL-cholesterol level was increased signiﬁcantly in group V
compared to that of group IV (Table 3).
 Effect of G. sylvestre leaves extract on antioxidant parameter
levels.
Plasma malondialdehyde (MDA) levels in groups III and V
showed a non signiﬁcant difference (p< 0.05) in relation to
those of groups I and II. Plasma MDA level was signiﬁcantly
increased in group IV compared to that of groups I and II.
Plasma MDA level was signiﬁcantly decreased in group V
compared to that of group IV (Table 4).
Plasma catalase level in group III was signiﬁcantly low
(p< 0.05) compared to that of groups I and II. Plasma cata-
lase levels in groups IV and V increased signiﬁcantly compared
to those of groups I and II. Plasma catalase level in group V
showed non signiﬁcant difference compared to that of group
IV (Table 4).
Erythrocyte superoxide dismutase (SOD) levels were signif-
icantly low (p< 0.05) in groups III and IV compared to those
of groups I and II. Erythrocyte SOD level in group V showed a
non signiﬁcant difference compared to that of groups I and II.
Table 1 Plasma glucose and insulin levels of normal rats (Group I), rats injected with citrate buffer (Group II), rats supplemented
with G. sylvestre leaves extract (Group III), STZ-diabetic rats (Group IV) and rats treated with G. sylvestre leaves extract post STZ-
diabetic induction (Group V).
Parameters Groups
Group I Group II Group III Group IV Group V
Glucose (mg/dl) 132.86 ± 0.66c 131.66 ± 0.47c 127.54 ± 0.93d 285.77 ± 2.39a 228.06 ± 2.68b
Insulin (ng/ml) 25.71 ± 0.46b 24.71 ± 0.89b 27.97 ± 0.62a 10.36 ± 0.19d 19.00 ± 0.60c
All data expressed as mean ± SD.
abcd Means superscripted with different letters are signiﬁcantly different at (p< 0.05).
Table 2 Plasma liver function enzymes level (alanine aminotransaminase, ALT and aspartate aminotransaminase, AST) of normal
rats (Group I), rats injected with citrate buffer (Group II), rats supplemented with G. sylvestre leaves extract (Group III), STZ-diabetic
rats (Group IV) and rats treated with G. sylvestre leaves extract post STZ-diabetic induction (Group V).
Parameters Groups
Group I Group II Group III Group IV Group V
ALT (U/L) 35.04 ± 0.72c 35.10 ± 0.12c 35.57 ± 0.36c 67.63 ± 0.34a 50.32 ± 0.36b
AST (U/L) 68.33 ± 0.93c 67.57 ± 0.78c 68.03 ± 0. 18c 88.81 ± 0.63a 74.37 ± 1.11b
All data expressed as mean ± SD.
abc Means superscripted with different letters are signiﬁcantly different at (p< 0.05).
Table 3 Plasma lipid proﬁle of normal rats (Group I), rats injected with citrate buffer (Group II), rats supplemented with G. sylvestre
leaves extract (Group III), STZ-diabetic rats (Group IV) and rats treated with G. sylvestre leaves extract post STZ-diabetic induction
(Group V).
Parameters Groups
Group I Group II Group III Group IV Group V
Triglycerides (mg/dl) 76.37 ± 0.66c 77.53 ± 0.42c 61.25 ± 1.17d 101.50 ± 0.45a 81.33 ± 0.58b
Cholesterol (mg/dl) 66.64 ± 0.87c 66.80 ± 0.39c 40.95 ± 0.52d 89.11 ± 0.31a 75.30 ± 1.05b
LDL-cholesterol (mg/dl) 10.57 ± 0.31c 10.43 ± 0.26c 9.16 ± 0.46d 12.46 ± 0.13a 11.43 ± 0.08b
HDL-cholesterol (mg/dl) 30.58 ± 0.47b 30.94 ± 0.21b 34.61 ± 0.55a 23.71 ± 0.46d 28.83 ± 0.51c
All data expressed as mean ± SD.
abcd Means superscripted with different letters are signiﬁcantly different at (p< 0.05).
Table 4 Antioxidant parameter levels of normal rats (Group I), rats injected with citrate buffer (Group II), rats supplemented with G.
sylvestre leaves extract (Group III), STZ-diabetic rats (Group IV) and rats treated with G. sylvestre leaves extract post STZ-diabetic
induction (Group V).
Parameters Groups
Group I Group II Group III Group IV Group V
MDA (nmol/ml) 241.33 ± 3.21bc 242.33 ± 5.51bc 235.67 ± 2.08c 255.33 ± 5.03a 244.67 ± 5.51b
Catalase (U/ml) 852.67 ± 4.19b 849.00 ± 6.00b 832.33 ± 5.51c 875.67 ± 7.02a 869.00 ± 1.00a
SOD (U/ml) 159.33 ± 9.07a 155.00 ± 6.00a 140.33 ± 2.52b 136.00 ± 2.65b 156.33 ± 3.21a
GSH (mg/dl) 30.63 ± 0.67b 28.73 ± 1.26c 31.67 ± 0.45b 32.70 ± 0.96a 31.23 ± 0.55ab
All data expressed as mean ± SD.
abc Means superscripted with different letters are signiﬁcantly different at (p< 0.05).
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crease compared to that of group IV (Table 4).
Plasma reduced glutathione (GSH) level was signiﬁcantly
decreased (p< 0.05) in group II compared to that of groupI. On the other hand, plasma GSH levels in groups III and
V showed a non signiﬁcant difference compared to that of
group I. Plasma GSH level in group IV increased signiﬁcantly
compared to that of group I. Plasma GSH level in group V
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IV (Table 4).
4. Discussion
G. sylvestre is an important medicinal plant used in different
systems of medicine as a remedy for the treatment of diabetes
(Jarald et al., 2008).
The present study showed a signiﬁcant decrease in plasma
glucose level (20.20%) in diabetic rats treated with G. sylvestre
leaves extract (18 mg/kg body weight) compared to that of un-
treated diabetic rats. Signiﬁcant increase in diabetic rats’ insu-
lin level post treated with G. sylvestre leaves extract conﬁrmed
our result. Moreover, glucose level might be decreased in trea-
ted diabetic rats as a result of decreasing gluconeogenesis that
was indicated by low levels of ALT and AST in treated dia-
betic rats compared to untreated diabetic rats.
This result was in agreement with Shanmugasundaram et al.
(1983) who reported that administration of dried leaf powder of
G. sylvestre decreased glucose levels as it controlled gluconeo-
genic enzymes (ALT and AST) and increased glycogen levels
in liver, kidney and muscle. Treated 27 type 1 diabetic patients
with water extract of G. sylvestre leaves (400 mg/day) for
12 months reduced blood glucose level (up to 35%) as a direct
effect of increasing exogenous insulin level (up to 50%)
(Shanmugasundaram et al., 1990). Chattopadhyay (1998) re-
ported that administration of alcoholic extract of G. sylvestre
leaves to Swiss albino rats fed by glucose increases the insulin
level. Bolkent et al. (2000) explained that the decrease in plasma
glucose levels might be due to the increase in insulin levels after
administration of gymnemic acid to diabetic rats. Gholap and
Kar (2005) discovered that gymnemic acid was capable of
reducing corticosteroid hormones in dexamethasone-induced
hyperglycemia in mice. Daisy et al. (2009) reported that plasma
glucose level reduced more than 50% in diabetic rats treated by
dihydroxy gymnemic triacetate (20 mg/kg b.w.) for 40 days
compared to untreated diabetic rats and they explain this
reduction as a result of increasing plasma insulin (50%), muscle
glycogen (77.1%) and liver glycogen (59.09%) content. In vivo
leaf and in vitro callus methanol extract of G. sylvestre
decreased blood glucose level (72.4%) in diabetic rats (Ahmed
et al., 2008) and that might be due to increased liver glycogen
content (Ahmed et al., 2010). The activities of phosphorylase
enzymes and sorbitol dehydrogenase were increased in diabetic
rabbits after treated with G. sylvestre extract (Venkatesham
et al., 2010).
This result was supported also by Yoshioka (1986) who
demonstrated that Gymnemic acid inhibited Na+ dependent
active glucose transport in the small intestine. Fushiki et al.
(1992) suggested that the G. sylvestre leaves extract inhibited
gastric inhibitory peptide (GIP). Sahu et al. (1996) reported
that the gymnemic acid molecules ﬁll the receptor location in
the absorptive external layers of the intestine thereby prevent-
ing the glucose absorption by the rat intestine. It was suggested
that gymnemic acid extract inhibited glucose uptake in the
intestine of guinea pig which occurred due to the effect of
gymnemic acid extract on the suppression of high K+ induced
contraction in guinea pig ileac longitudinal muscles (Shimizu
et al., 1997). The treatment with high concentrations of
G. sylvestre leaves extract reduced the levels of glucose in albi-
no Wistar rats and that might be due to the effect of gymnemicacid on the inhibition of glucose uptake in the intestine (sujin
et al., 2008). Hypoglycemic potential of G. sylvestre, Tinospora
cordifolia, Eugenia jambolana and Aegle marmelos might be
due to their effect on inhibition of the activity of a-amylase
resulting in the delayed digestion of the dietary carbohydrates,
so the liberated glucose from the intestine lumen to the circu-
lation decreased (Ahmed et al., 2011).
Plasma insulin levels signiﬁcantly increased (83.40%) in
diabetic rats treated with G. sylvestre leaves extract (18 mg/
kg body weight) compared to that of untreated diabetic rats.
Our result was in accordance with Persaud et al. (1999) who
suggested that alcoholic extract of G. sylvestre leaves increased
insulin release in vitro by two mechanisms: (1) the major mode
of action was through b-cell plasma membrane permeability,
(2) the pores formed by plasma membrane disruption. The
number of pancreatic b-cells in the diabetic rats doubled after
administration of alcoholic extract of G. sylvestre leaves
(Shane-McWhorter, 2001). Daisy et al. (2009) reported that
the insulin levels in diabetic rats increased (50%) after treat-
ment with dihydroxy gymnemic triacetate and that might be
due to the stimulation of insulin secretion from regenerated
or residual b-cells by dihydroxy gymnemic triacetate. Liu
et al. (2009) suggested that the increase in insulin secretion
from mouse b-cells and isolated human islets after the admin-
istration of low concentration of G. sylvestre leaves extract
might be partially dependent on the increase in Ca+ inﬂux.
Degenerative changes in pancreatic b-cells were minimized
and normal morphology maintained in alloxan induced dia-
betic rats after administration of gymnemic acid (Ahmed
et al., 2010). Microscopy studies of pancreas of animals receiv-
ing G. sylvestre extract showed that nuclei of endocrinocytes
were signiﬁcantly enlarged in all sections of the organ with
the same volume fraction and area of pancreatic islets. The re-
sult agreed completely with investigations proposed that use of
G. sylvestre increased the endogenous levels of insulin, possibly
due to regeneration of pancreas cells (Venkatesham et al.,
2010).
In the present study, rats treated with G. sylvestre leaves ex-
tract post STZ-diabetic induction showed a signiﬁcant de-
crease in triglyceride, cholesterol and LDL-cholesterol and
showed a signiﬁcant increase in HDL-cholesterol as compared
to that of untreated diabetic rats. Decreasing levels of triglyc-
eride, cholesterol and LDL-cholesterol and increasing level of
HDL-cholesterol might be due to an increase in insulin which
caused an increased activity of lipoprotein lipase (Facilitated
chylomicron transport through cell membranes) and a de-
creased activity of hormone-sensitive lipase (converted neutral
fats into free fatty acids). This result was in agreement with
Daisy et al. (2009) and Aralelimath and Bhise (2012) who re-
ported that increasing insulin secretion after administration
of G. sylvestre extract led to a decrease of cholesterogenesis
and fatty acid synthesis.
This result was supported also by Mall et al. (2009) who
reported that G. sylvestre decreases total cholesterol, LDL-cho-
lesterol, VLDL-cholesterol and triglyceride levels in diabetic
rats and that could be due to the presence of hypolipidemic
agent such as sitosterol in the aqueous leaf extract. G. sylvestre
inhibited the intestinal absorption of oleic acid in rats, which
suggested the possibility of G. sylvestre to inhibit lipid absorp-
tion (Wang et al., 1998). Shigematsu et al. (2001) reported that
administration of G. sylvestre leaves extract decreased the total
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ide levels in the serum of rats fed with a high fat diet or normal
fat diet and that might be due to the effect of G. sylvestre in
increasing neutral sterols and acid steroids excretion into feces.
Luo et al. (2007) discovered the ability of G. sylvestre water ex-
tract to prevent the genetic obesity by improving the cholesterol
metabolism and inhibiting polyphagia. Ishijima et al. (2008)
suggested that gymnemic acid might have some pharmacologi-
cal activities including antidiabetic activity and lipid lowering
effects via the inhibition of glycerol-3-phosphate dehydroge-
nase activity in vitro. The intra peritoneal fat and fat drop vac-
uoles on the epithelium of renal tubules were scattered by
administration of the G. sylvestre extract (Mahajan et al.,
2011). Lipid lowering activity of ﬂavonoids and saponins ex-
tracted from G. sylvestre might be due to the inhibition of pan-
creatic lipase activity (Manish et al., 2011).
It was apparent from our results that plasma lipid
peroxidation level decreased and erythrocyte superoxide dis-
mutase level increased in rats treated with G. sylvestre leaves
extract post STZ-diabetic induction compared to untreated
diabetic rats.
Ohmori et al. (2005) discovered the antioxidant ability of G.
sylvestre, when they studied the antioxidant activity of six teas
against free radicals and LDL oxidation in 10 healthy volun-
teers ranging from 20 to 22 years of age. In vitro G. sylvestre
alcoholic leaf extract showed antioxidant ability by inhibiting
1,1-diphenyl-2-picrylhdrazyl (DPPH) and scavenging superox-
ide and hydrogen peroxide (Rachh et al., 2009). Administra-
tion of G. sylvestre extract to diabetic rats increased
superoxide dismutase activity and decreased lipid peroxide
by either directly scavenging the reactive oxygen species, due
to the presence of various antioxidant compounds, or by
increasing the synthesis of antioxidant molecules (albumin
and uric acid) (Vasi and Austin, 2009). Fazal et al. (2011)
found that the maximum scavenging activity of ethanolic ex-
tract of G. sylvestre in vitro was 54.4% at concentration
250 lg/ml. Some poly herbal ayurvedic formulations like Hyp-
onidd and Dihar containing G. sylvestre extract had shown
antioxidant activity by increasing superoxide dismutase, gluta-
thione and catalase levels in rats (Mahajan et al., 2011). Kang
et al. (2012) reported that feeding G. sylvestre extract to dia-
betic rats decreased lipid peroxidation levels by 31.7% in ser-
um, 9.9% in liver and 9.1% in kidney. It also decreased the
activity of glutathione peroxidase in cytosolic liver and
glutamate pyruvate transaminase in serum to normal levels.
5. Conclusion
It can be concluded that, G. sylvestre leaves extract exhibit
antidiabetic activity, so it is recommended to use it as a com-
plementary medicine in diabetes mellitus. Hence, clinical stud-
ies on G. sylvestre leaves extract as a complementary medicine
are needed.References
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